Teguh Triyono

Teguh Triyono

Auto-generated profile, based on publicly available information

Teguh Triyono

Department of Clinical Pathology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada Yogyakarta Indonesia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2013 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
SPS. Panzer
S. Panzer
SES. Engelbrecht
S. Engelbrecht
MCM. F. Cole‐Sinclair
M. F. Cole‐Sinclair
EWE. M. Wood
E. M. Wood
SWS. Wendel
S. Wendel
HRH. W. Reesink
H. W. Reesink

1 July 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
WWWidya Wasityastuti
Widya Wasityastuti
YYYoshihiko Yano
Yoshihiko Yano
NRNeneng Ratnasari
Neneng Ratnasari
TTTeguh Triyono
Teguh Triyono
CTCatharina Triwikatmani
Catharina Triwikatmani
YHYoshitake Hayashi
Yoshitake Hayashi

23 October 2017 in Virology Journal
Verified
Journal Article
Open access
PDF file
YMYan Mardian
Yan Mardian
YYYoshihiko Yano
Yoshihiko Yano
WWWidya Wasityastuti
Widya Wasityastuti
NRNeneng Ratnasari
Neneng Ratnasari
YLYujiao Liang
Yujiao Liang
YHYoshitake Hayashi
Yoshitake Hayashi
Occult hepatitis B infection (OBI) is defined as the presence of hepatitis B virus (HBV) DNA in the serum and/or liver in HBsAg-negative individuals. OBI is associated with the risk of viral transmission, especially in developing countries, and with progressive liver disease and reactivation in immunosuppressive patients. The objective of this study was to evaluate the relation of OBI to HLA-DP single nucleotide polymorphisms (SNPs) encoding antigen-binding sites for the immune response to HBV infection. As HLA-DP variants affect the mRNA expression of HLA-DPA1 and HLA-DPB1 in the liver, we hypothesised that high levels of HLA-DPA1 and HLA-DPB1 expression favour OBI development. The study enrolled 456 Indonesian healthy blood donors (HBsAg negative). OBI was defined as the presence of HBV-DNA in at least two of four open reading frames (ORFs) of the HBV genome detected by nested PCR. SNPs in HLA-DPA1 (rs3077) and HLA-DPB1 (rs3135021, rs9277535, and rs2281388) were genotyped using real-time Taqman® genotyping assays. Of 122 samples positive for anti-HBs and/or anti-HBc, 17 were determined as OBI. The minor allele in rs3077 was significantly correlated with OBI [odds ratio (OR) = 3.87, 95% confidence interval (CI) = 1.58–9.49, p = 0.0015]. The prevalence of the minor allele (T) was significantly higher in subjects with OBI than in those without (59% and 33%, respectively). The combination of haplotype markers (TGA for rs3077–rs3135021–rs9277535) was associated with increased risk of OBI (OR = 4.90, 95%CI = 1.12–21.52 p = 0.038). The prevalence of OBI was highest in the isolated anti-HBc group among the three seropositive categories: anti-HBs <500 mIU/ml, anti-HBs ≥500 mIU/ml, and isolated anti-HBc (29.41%, p = 0.014). Genetic variants of HLA-DP and the presence of anti-HBc are important predictors of OBI in Indonesian blood donors. Ref: KE/FK/194/EC; registered 01 March 2013. Continuing approval Ref: KE/FK/536/EC; registered 12 May 2014.

12 August 2014 in Journal of Clinical Apheresis
Verified
Journal Article
Closed access
PDF file
TTTeguh Triyono
Teguh Triyono
HVHans Vrielink
Hans Vrielink

27 September 2023 in Vox Sanguinis
Verified
Journal Article
Open access
YFYoke‐Lin Fung
Yoke‐Lin Fung
RARamir Moreno Alcantara
Ramir Moreno Alcantara
LCLeonardo Brereton Cavalli
Leonardo Brereton Cavalli
JCJen‐Wei Chen
Jen‐Wei Chen
YCYun‐Yuan Chen
Yun‐Yuan Chen
NTNelson Hirokazu Tsuno
Nelson Hirokazu Tsuno
Background and Objectives: Securing an adequate blood supply relies on accurate knowledge of blood donors and donation practices. As published evidence on Asian populations is sparse, this study aims to gather up‐to‐date information on blood donors and donation practices in Asia to assist planning and strategy development.Materials and Methods: Ten blood collection agencies (BCAs) provided 12 months' data on donors who met eligibility criteria or were deferred, as well as details of their donation practices. Body mass index and blood volumes were calculated and analysed.Results: Data on 9,599,613 donations and 154,834 deferrals from six national and four regional BCAs revealed varied donation eligibility and collection practices. Seven used haemoglobin (Hb) criteria below the World Health Organization anaemia threshold. Seven accepted donors weighing <50 kg. Data collection on the weight and height of donors and on deferrals was inconsistent, often not routine. Deferred donors appear to weigh less, with corresponding lower estimated blood volume.Conclusion: The diversity in eligibility criteria and donation practices reflects each BCA's strategy for balancing donor health with securing an adequate blood supply. Use of lower Hb criteria substantiate their appropriateness in Asia and indicate the need to define Hb reference intervals relevant to each population. We encourage routine gathering of donor weight and height data to enable blood volume estimation and local optimization of donation volumes. Blood volume estimation formulae specific for the Asian phenotype is needed. Information from this study would be useful for tailoring donation criteria of Asian donors around the world.

30 September 2020 in Veterinary World
Verified
Journal Article
Open access
HWHevi Wihadmadyatami
Hevi Wihadmadyatami
PHPuspa Hening
Puspa Hening
UKUlayatul Kustiati
Ulayatul Kustiati
DKDwi Liliek Kusindarta
Dwi Liliek Kusindarta
TTTeguh Triyono
Teguh Triyono
SSSupriatno Supriatno
Supriatno Supriatno
Background and Aim: Ocimum sanctum (OS) is a herbal plant, which is easy to find and is widely used as an alternative medication. The previous studies have shown that several species of OS extract have therapeutic properties, and in some cases, antitumor properties. Furthermore, several data have shown the antiproliferative effects of OS extract in cases of breast cancer, human fibrosarcoma, and oral cancer. Lung adenocarcinoma is a major cause of male cancer worldwide; however, the effect of OS (of Indonesian origin) on the metastasis of human alveolar pulmonary adenocarcinoma A549 cells remains unclear. This study aimed to analyze the antiangiogenic effects of OS ethanolic extract in A549 lung adenocarcinoma cells. Materials and Methods: An angiogenesis assay was performed by seeding A549 cells on extracellular matrix solution and observing tube formation using an inverted microscope. Enzyme-linked immunosorbent assay for αvβ3, matrix metalloproteinase (MMP)-2, and MMP-9 was performed by analyzing the cell lysate after a given treatment. Results: OS ethanolic extract significantly inhibited tube formation of A549 cells and suppressed the expression of integrin αvβ3, MMP-2, and MMP-9. Conclusion: Our findings indicate that OS ethanolic extract disrupts angiogenesis of A549 cells, which may result from the disruption of cell migration and proliferation as a consequence of downregulation of αvβ3, MMP-2, and MMP-9. Taken together, OS ethanolic extract may represent a good therapeutic candidate for the treatment of metastasis in lung adenocarcinoma. Further studies are warranted to further establish the efficacy of OS in the treatment of lung adenocarcinoma.